Ibrutinib-rituximab safe and effective in the frontline for elderly MCL
Preetesh Jain • 1 Jul 2019
Will knowledge of the molecular pathology of lymphoma improve clinical trials?
David Maloney et al. • 17 Sep 2019
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.